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A 25-year-old man with no personal or family history of interest attended the out-patient clinic of the Complejo Hospitalario 
de Granada, Granada, Spain, in 2017 with multiple, 
non-pruritic, atrophic, mildly indurated, brownish, 
erythematous patches on his back of one year’s 
duration [Figure 1]. He denied any regular medication 
use or having had any previous conditions. There was 
no history of trauma preceding the appearance of 
the skin lesions. Routine laboratory tests were within 
normal limits, including a complete blood cell count, 
urinalysis, thyroid profile, protein electrophoresis  and 
general biochemistry, antinuclear/extractable nuclear 
antibody and rheumatoid factor tests. Immunoglobulin 
M and G tests for Borrelia burgdorferi were negative. 
A histopathological examination showed a normal 
epidermis with a slight mononuclear perivascular 
infiltrate in the papillary dermis and focal sclerosis 
with hyalinisation of the reticular dermis [Figure 2]. 
Narrowband ultraviolet B phototherapy was proposed 
as the first line of treatment; however, the patient 
refused to consent to the therapy.
Comment
Idiopathic atrophoderma of Pasini and Pierini (IAPP) 
is a rare, exclusively cutaneous condition which occurs 
most frequently in female patients, with a peak 
incidence in the second and third decades of life.1 
Overall, fewer than 100 cases have been reported 
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Figure 1: Photograph of multiple round, pink-coloured, atrophic plaques on the back of a 25-year-old male patient.
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in the literature.2 The pathophysiology of this entity 
remains unknown and the role of Borrelia burgdorferi 
infections remains controversial.2 Some researchers 
believe that IAPP should be included as a manifestation 
of the spectrum of localised scleroderma.3 Some cases 
of familial IAPP have been described; however, a 
genetic link has not yet been confirmed.2 
From a clinical point of view, IAPP lesions may 
present in various patterns (i.e. rounded, oval or 
circular) and may be single or multiple.3 The edges 
of the patches are usually well defined and multiple 
lesions, such as in the present case, have been 
described as having a ‘swiss cheese’ or ‘footprints in the 
snow’ appearance. The sites predominantly affected 
are the lower and upper extremities or the trunk and 
it is not unusual for the lesions to follow a zosteriform 
or blaschkoid pattern.3 The condition can cause pain, 
pruritus or even paresthesia.
The pathological findings of IAPP are variable. 
In many cases, no alterations can be observed in the 
epidermis or dermis.2,3 The most common finding is a 
thinning of the affected dermis and no quantitative or 
qualitative alterations have yet been reported on the 
appendages.3 Collagen changes can include atrophy, 
sclerosis, fragmentation and hyalinisation.2 Elastic fibre 
changes may be variable and reduction and frag-
mentation similar to that of anetoderma cases have 
been reported.4
The therapeutical approach to IAPP includes the 
use of different medications such as antibiotics (i.e. 
penicillin and tetracyclines) and hydroxychloroquine 
(with good response in cases with associated lupus) as 
well as topical treatments such as calcineurin inhibitors 
(although with variable responses).5–7 Treatment with 
a Q-switched Alexandrite laser has also been reported 
to result in the clinical improvement of hyperpigmented 
lesions.8 
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Figure 2: Haematoxylin and eosin stain at x4 magnification 
showing a normal epidermis with discrete thinning of the 
upper dermis (arrow) and mild hyalinisation and sclerosis on 
the reticular dermis (arrowhead). 
